April 15, 2014:

The Big Ten Cancer Research Consortium announces Zoe Holt, CCRP, will serve as senior project manager. Holt will provide project management for Big Ten CRC protocols as well as contribute to the continued growth of the consortium by providing administrative support for the meetings and activities of the steering committee and cancer center directors, overseeing the efforts to establish an expedited IRB process, and developing institutional relationships to support the consortium’s fundraising priorities.

“I am thrilled to further support the Big Ten Cancer Research Consortium and look forward to working with such accomplished oncologists and prestigious academic research institutions,” said Holt. “Our work together holds great promise for furthering science and improving the lives of all patients with cancer. I am excited to be a part of this unique collaboration.”

Holt earned her bachelor’s degree from Indiana University, where she studied chemistry, and is a SoCRA Certified Clinical Research Professional. Her experience includes project management and program development in both commercial and nonprofit clinical research organizations. Holt is a project manager for Hoosier Oncology Group, which serves as the administrative headquarters of the Big Ten Cancer Research Consortium.

“At this stage in the growth of the Big Ten CRC, with working groups generating concepts and potential trials in development, we are ready to bring a project management professional to the team,” said Cyndi Burkhardt, executive director. “Zoe’s record of excellence managing clinical trials for the Hoosier Oncology Group is a great asset to the consortium.”

Jessica Roy will continue to support the research development process for Big Ten CRC trials, from initial concept proposals to protocol approval. As research development director, Roy is the first point of contact for the consortium and will continue to work with clinical trial working groups.

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in student-athletes’ lives and emphasize the values of integrity, fairness and competitiveness. The broad-based athletic programs of the 12 Big Ten institutions provide in excess of $141 million in direct financial aid to more than 8,200 student-athletes playing on more than 300 teams in 43 different sports. The Big Ten sponsors 26 official conference sports, 13 for men and 13 for women, and will add men’s and women’s lacrosse as the 27th and 28th official sports for the 2014-15 academic year. For more information, visit www.bigten.org.